Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors
Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
This is a phase 1 study to evaluate the safety of intralesional talimogene laherparepvec
administration in pediatric subjects with advanced non-CNS tumors that are amenable to direct
injection